Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Ovarian Neoplasms 21 Neoplasms 16 Neuroblastoma 14 Small Cell Lung Carcinoma 13 Carcinoma, Ovarian Epithelial 12 Fallopian Tube Neoplasms 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Lung Neoplasms 10 Recurrence 8 Leukemia 8 Leukemia, Myeloid, Acute 7 Uterine Cervical Neoplasms 6 Unspecified Adult Solid Tumor, Protocol Specific 6 Neoplasm Metastasis 6 Lymphoma 6 Sarcoma, Ewing 5 Endometrial Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Brain Neoplasms 5 Sarcoma 4 Lymphoma, Follicular 4 Glioma 4 Central Nervous System Neoplasms 4 Burkitt Lymphoma 4 Blast Crisis 4 Rhabdomyosarcoma 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Myelodysplastic Syndromes 3 Meningeal Carcinomatosis 3 Medulloblastoma 3

Interventions

Nivolumab 8 Paclitaxel 6 Sirolimus 5 Bevacizumab 5 temsirolimus 4 Pemetrexed 4 Ipilimumab 4 Docetaxel 4 Carboplatin 4 ARRY-334543 4 Gemcitabine 3 Erlotinib Hydrochloride 3 olaparib 2 linrodostat 2 apatinib 2 anlotinib 2 abemaciclib 2 Vorinostat 2 Sunitinib 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2 Everolimus 2 Doxorubicin 2 Dasatinib 2 Chlorogenic Acid 2 Cetuximab 2 6-(6-(1-methyl-1H-pyrazol-4-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-ylsulfanyl)quinoline 2 vorolanib 1 vistusertib 1 trametinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Cancer × Topotecan × Clear all

NCT00770731 2013-02-13

Study of Temsirolimus, Topotecan, and Bortezomib

M.D. Anderson Cancer Center

Phase 1 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡